By: Staff Writer June 16, Colombo (LNW): Sri Lanka’s pharmaceutical regulatory environment is facing increasing scrutiny as concerns mount over pricing policies, regulatory delays, and their potential impact on medicine availability. Industry representatives claim that a combination of prolonged approval procedures and aggressive pricing expectations has created significant obstacles for international pharmaceutical suppliers, particularly compa…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.